Development of Timed Release Vaginal Mucosal Cloprostenol for Farrowing Management in Sows
<b>Background/Objectives:</b> Controlling the timing of farrowing to occur during working hours presents an opportunity to improve supervision and reduce piglet neonatal mortality. However, the use of non-therapeutic injectable drugs is often limited in commercial swine production. This study aimed to develop a cloprostenol vaginal mucosal delivery system for induction of farrowing. To achieve this, two vaginal tablets containing cloprostenol were formulated for simultaneous insertion: an immediate-release (IR) tablet and a delayed release (DR) tablet, the latter designed for a 6 h delay before release. <b>Methods:</b> In vitro release studies demonstrated that the IR tablet released 100% of the drug within 5 min, while the DR tablet, initiated release after four hours and achieved approximately 80% release at six hours, aligning with the targeted release profile. To evaluate the efficacy of the optimized formulations, an in vivo study was conducted using 121 mixed parity Landrace × Large White sows that were assigned to one of four treatments, control (n = 23) received no treatment; IM (n = 26) received 185 µg of cloprostenol via intramuscular injection; IR (n = 36) received a 100 µg IR tablet by vaginal deposition; and IR + DR (n = 36) received both IR and DR tablets by vaginal deposition, to simulate split-dose delivery. <b>Results:</b> Control sows experienced longer (<i>P</i> < 0.001) intervals to farrowing compared to those receiving cloprostenol treatments. Additionally, differences (<i>P</i> < 0.05) were observed in interval from treatment to farrowing time among the treatments, with the interval for IM sows being shorter than for IR (<i>P</i> < 0.001) and IR + DR (<i>P</i> = 0.001) sows. <b>Conclusions:</b> These findings confirm that the vaginal route offers an alternative, non-invasive, method for farrowing induction in sows, facilitating farrowing supervision during working hours and potentially reducing piglet mortality.
Authors
- Preechaphon Taechamaeteekul (ORCID: https://orcid.org/0000-0002-9856-1847)
- Roy N. Kirkwood (ORCID: https://orcid.org/0000-0002-3294-8301)
- Kiro Petrovski (ORCID: https://orcid.org/0000-0003-4016-2576)
- Sanjay Garg (ORCID: https://orcid.org/0000-0001-7253-2629)
- Padet Tummaruk (ORCID: https://orcid.org/0000-0001-7000-4371)
- AHM Musleh Uddin (ORCID: https://orcid.org/0000-0002-4393-3711)
- Yunmei Song (ORCID: https://orcid.org/0000-0003-0008-5895)
Institutions
- Chulalongkorn University (TH)
- The University of Adelaide (AU)
Publication Details
- Journal
- Pharmaceutics
- Published
- 2025-09-15
- DOI
- https://doi.org/10.3390/pharmaceutics17091198
- Primary Topic
- Animal Nutrition and Physiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of South Australia